Sanofi firm against Dengvaxia refund, indemnification amid looming civil suit

FRENCH pharmaceutical giant Sanofi on Monday said it has yet to receive a formal document from the Department of Health (DoH) on the civil case it would file against the company regarding its refusal to refund used vials of anti-dengue vaccine Dengvaxia and indemnifying alleged victims of the drug.

"We have not received any formal document in relation to the civil case to be filed by the Department of Health in relation to the company’s response to the second request to refund the government for the used doses of Dengvaxia," the pharmaceutical firm said in a statement.